Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials.
The DOI matches its Crossref record; 69 of the 70 references it cites were found in a registry or an index.
Abstract
Objective Weight gain is one of the most challenging issues in patients with schizophrenia treated with antipsychotics. Several meta-analyses have been conducted to review the efficacy of topiramate in reducing weight, however, several issues regarding the methodology had arisen of which make the results remain ambiguous. Methods We conducted a meta-analysis of randomised controlled trials about the use of topiramate in patients with schizophrenia for weight reduction. Ten double-blinded randomised placebo-controlled trials and seven open-label randomised controlled trials included 905 patients. Results Patients treated with topiramate experienced a greater reduction in body weight and BMI. Patients in countries of the lower overweight population showed more significant BMI reduction. Besides, studies from the Middle East and South Asia showed the greatest effect in body weight change, followed by East Asia, then Europe/America. Topiramate group was outperformed control group with significant psychopathology improvement. No difference between two groups regarding the overall side effects. Conclusions Topiramate was significantly superior to control group in mitigating weight gain and psychopathology in antipsychotic-treated patients with schizophrenia. The effects of topiramate augmentation need further investigations in larger definitive studies using methodological rigor and thorough assessments.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Metformin (1000 mg total daily dose) and topiramate (100 mg/d) counteract the effects of some weight gain-promoting agents, particularly antipsychotics and can be considered as adjunctive therapy (topiramate: mean difference, −3.76 kg; 95% CI, −4.92 kg to −2.69 kg; metformin: mean difference, −3.27 kg; 95% CI, −4.66 kg to −1.89 kg).79,80”
From Obesity Management in Adults: A Review (2023) · cites this paper as [79]
Citations
Cites
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations
Guyatt, G. H., Oxman, A. D., Vist, G. E., Kunz, R., Falck-Ytter, Y., Alonso-Coello, P., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39489.470347.ad · Cited by 23,305
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., & Altman, D. G. (2009) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.06.005 · Cited by 19,575
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Flegal, K. M., Kit, B. K., Orpana, H., & Graubard, B. I. (2013) · JAMA · doi:10.1001/jama.2012.113905 · Cited by 3,998
Leucht, S., Cipriani, A., Spineli, L., Mavridis, D., Örey, D., Richter, F., Samara, M., Barbui, C., Engel, R. R., Geddes, J. R., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(13)60733-3 · Cited by 2,561 · cited 1×
“Baseline BPRS scores were converted to PANSS scores (Leucht et al., 2013) for subgroup analysis of patient’s baseline psychopathology.”
MethodAntipsychotic-induced weight gain: a comprehensive research synthesis
Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., & Weiden, P. J. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.11.1686 · Cited by 2,382 · cited 1×
“The tragedy of the second-generation antipsychotics (SGAs) treatment on weight gain is well-established; clozapine, olanzapine and risperidone are among the worst (Allison et al., 1999; Parsons et al., 2009).”
BackgroundLEUCHT, S., KANE, J., KISSLING, W., HAMANN, J., ETSCHEL, E., & ENGEL, R. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.04.008 · Cited by 1,226
Research works printed but not linked: 10
- 10.3969/j.issn.1671-0800.2012.09.008 · doi:10.3969/j.issn.1671-0800.2012.09.008
- Jiang J., 2013, China Modern Doctor, 51, 78
- 10.3969/j.issn.1671-0800.2011.06.034 · doi:10.3969/j.issn.1671-0800.2011.06.034
- 10.3969/j.issn.1002-7386.2010.21.015 · doi:10.3969/j.issn.1002-7386.2010.21.015
- WHO, 2014, Global Nutrition Targets 2025: Childhood overweight policy brief (WHO/NMH/NHD/14.6)
- WHO, 2016, World Health Day 2016: WHO calls for global action to halt rise in and improve care for people with diabetes
- 10.3969/j.issn.1002-0152.2013.06.003 · doi:10.3969/j.issn.1002-0152.2013.06.003
- 10.16766/j.cnki.issn.1674-4152.2016.06.017 · doi:10.16766/j.cnki.issn.1674-4152.2016.06.017
- 10.3969/j.issn.1673-9701.2010.20.004 · doi:10.3969/j.issn.1673-9701.2010.20.004
- 10.3969/j.issn.1672-187X.2016.04.001-0001-03 · doi:10.3969/j.issn.1672-187x.2016.04.001-0001-03
Cited by
Obesity Management in Adults: A Review
Elmaleh-Sachs, A., Schwartz, J. L., Bramante, C. T., Nicklas, J. M., Gudzune, K. A., & Jay, M. (2023) · JAMA · doi:10.1001/jama.2023.19897 · Cited by 813
Vancampfort, D., Firth, J., Correll, C. U., Solmi, M., Siskind, D., De Hert, M., Carney, R., Koyanagi, A., Carvalho, A. F., Gaughran, F., et al. (2019) · World Psychiatry · doi:10.1002/wps.20614 · Cited by 227
Psychotropic Drug–Related Weight Gain and Its Treatment
McIntyre, R. S., Kwan, A. T. H., Rosenblat, J. D., Teopiz, K. M., & Mansur, R. B. (2024) · American Journal of Psychiatry · doi:10.1176/appi.ajp.20230922 · Cited by 113
The Burden of Antipsychotic-Induced Weight Gain and Metabolic Syndrome in Children
Libowitz, M. R., & Nurmi, E. L. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.623681 · Cited by 99
“A meta-analysis of 10 studies of adjunctive topiramate (an antiepileptic drug known to reduce appetite) for AIWG, found topiramate mitigated weight gain in AP-treated adults (303).”
BackgroundThe effects of antipsychotic medications on microbiome and weight gain in children and adolescents
Bretler, T., Weisberg, H., Koren, O., & Neuman, H. (2019) · BMC Medicine · doi:10.1186/s12916-019-1346-1 · Cited by 105
Metadata
- Authors
- Goh, K. K., Chen, C.-H., & Lu, M.-L.
- Affiliations
- Wan Fang Hospital (TW)
- Corresponding author
- Lu, Mong-Liang
- Venue
- International Journal of Psychiatry in Clinical Practice
- Publisher
- Informa UK Limited
- Published
- 2018-03-20
- Volume
- 23
- Issue
- 1
- Pages
- 14-32
- ISSN
- 1365-1501 (ISSN-L)
- 1471-1788
- OpenAlex
- W2793131601
- Cited by
- 40
- References
- 70
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 3 · 2021: 6 · 2020: 1 · 2019: 3 · 2018: 1
- FWCI
- 0.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Psychiatry in Clinical Practice (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Taipei Medical University (105-wf-eva-04 and 106-eva-13)
- Ministry of Science and Technology (MOST 105-2314-B-038-043-MY3)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
- Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
- Keywords
- topiramate, schizophrenia, antipsychotic-induced weight gain, weight loss, body mass index, psychopathology, antipsychotic augmentation, adverse effects
- MeSH terms
- Topiramate, Humans, Hypoglycemic Agents, Schizophrenia, Antipsychotic Agents, Weight Gain, Randomized Controlled Trials as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials. https://app.cochat.ai/papers/10.1080/13651501.2018.1449864
- The paper
- Goh, K. K., Chen, C.-H., & Lu, M.-L. (2019). Topiramate mitigates weight gain in antipsychotic-treated patients with schizophrenia: meta-analysis of randomised controlled trials. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/13651501.2018.1449864
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.